BCR and myeloid sarcoma: We identified gender, BCR and T2LV as the explanatory variables in the best predictive model to distinguish MS and SDCNS patients (sensitivity 0.91, specificity 0.68, AUC 0.86), where female gender, higher BCR and lower T2LV predisposed patients to a diagnosis of SDCNS.